Medications

Merck to pay $3.85B for hepatitis C drug developer

Merck & Co. will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies ...

Jun 09, 2014
popularity not rated yet | comments 0

Toward a better drug against malaria

A research team led by Prof. Dr. Carola Hunte has succeeded in describing how the antimalarial drug atovaquone binds to its target protein. The scientists used x-ray crystallography to determine the three-dimensional ...

Jun 06, 2014
popularity not rated yet | comments 0

Opioid overdose prevention programs may reduce deaths

Community opioid overdose prevention programs (OOPPs)—including the use of naloxone for rapid drug reversal—can improve bystander responses to overdose of heroin and related drugs, according to a review in the June Journal of ...

Jun 03, 2014
popularity not rated yet | comments 0